<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02436954</url>
  </required_header>
  <id_info>
    <org_study_id>KUH1160084</org_study_id>
    <nct_id>NCT02436954</nct_id>
  </id_info>
  <brief_title>Regional Cerebral Oxygen Saturation in Laparoscopic Surgery</brief_title>
  <official_title>Impact of Neuromuscular Blockade on Cerebral Oxygen Saturation in Laparoscopic Surgery Employ Carbon Dioxide-pneumoperitoneum</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Konkuk University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Konkuk University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      While few studies have determined the optimal intra-abdominal CO2 insufflation pressure to
      achieve optimal surgical condition during LCs with deep-NMB and moderate-NMB in laparoscopic
      cholecystectomy (LC), previous studies suggested that the use of deep neuromuscular blockade
      (deep-NMB) can improve surgical condition and reduce the pressure for CO2 insufflation to
      achieve &quot;optimal surgical space condition&quot;.

      this difference in the pressure of intra-abdominal CO2 insufflation due to different
      strategies employing deep-NMB and moderate-NMB for LC may produce possible difference in
      patient's respiratory pattern and cerebral oxygenation. Although previous study (studies)
      showed that intra-abdominal CO2 insufflation (10-12 mmHg) decreases cerebral oxy-hemoglobin
      (HbO2) and total Hb measured by near-infrared spectroscopy (NIRS) during laparoscopic
      cholecystectomy (LC), few studies have speculated possible impact of different degree of NMB
      and intra-abdominal CO2 insufflation pressure on patient's cardiorespiratory profile and
      cerebral oxygenation, so far.

      The present study determines and compares the changes CO2 absorption and cerebral oxygenation
      (cerebral perfusion) after applying CO2 insufflation with different intra-peritoneal pressure
      8 vs 12 mmHg during deep-NMB.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>regional cerebral oxygen saturation 1</measure>
    <time_frame>1 min</time_frame>
    <description>1 min after the initiation of pneumoperitonium</description>
  </primary_outcome>
  <primary_outcome>
    <measure>regional cerebral oxygen saturation 2</measure>
    <time_frame>2 min</time_frame>
    <description>2 min after the initiation of pneumoperitonium</description>
  </primary_outcome>
  <primary_outcome>
    <measure>regional cerebral oxygen saturation 3</measure>
    <time_frame>3 min</time_frame>
    <description>2 min after the initiation of pneumoperitonium</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>end-tidal carbon dioxide 1</measure>
    <time_frame>1 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>end-tidal carbon dioxide 2</measure>
    <time_frame>2 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>end-tidal carbon dioxide 3</measure>
    <time_frame>3 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>repiratory rate</measure>
    <time_frame>3 min</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cholecyctitis</condition>
  <arm_group>
    <arm_group_label>CO2 insufflation at intra-abdominal pressure 8 mmHg</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>CO2 insufflation with intra-abdominal pressure 8 mmHg during deep-NMB</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CO2 insufflation at intra-abdominal pressure 12 mmHg</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CO2 insufflation with intra-abdominal pressure 12 mmHg during deep-NMB</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CO2 insufflation at intra-abdominal pressure 8 mmHg</intervention_name>
    <arm_group_label>CO2 insufflation at intra-abdominal pressure 8 mmHg</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CO2 insufflation at intra-abdominal pressure 12 mmHg</intervention_name>
    <arm_group_label>CO2 insufflation at intra-abdominal pressure 12 mmHg</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  cholecystitis

          -  provision of written informed consent

        Exclusion Criteria:

          -  COPD

          -  asthma

          -  low LV ejection fraction
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2015</study_first_submitted>
  <study_first_submitted_qc>May 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2015</study_first_posted>
  <last_update_submitted>June 17, 2015</last_update_submitted>
  <last_update_submitted_qc>June 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Konkuk University Medical Center</investigator_affiliation>
    <investigator_full_name>Tae-Yop Kim, MD PhD</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

